- RSS Feed
- 2023
- AfterWork free beer networking event on March 15th
- Progress is the best medicine: Minister Dulig visits companies and institutes in the healthcare sector
- BioCityfit! - Bike check on 21.03.2023/XNUMX/XNUMX
- Event: "Orphan Drugs - Medicines for the Treatment of Rare Diseases"
- New call for funding from February 16: Saxony continues validation of promising research results
- Digitization - Life Science Stammtisch in the BIO CITY Bistro on 22.03.
- Top care for cancer patients in Saxony and Thuringia
- University of Leipzig: Annette Beck-Sickinger honored for significant research achievements
- Innovation Award of the German BioRegions 2023
- Ministry of Science launches "science on stage" ideas competition
- Application start for technology funding
- 2022
- First in Europe: All approved CAR-T cell therapy products are available at the University Hospital Leipzig (UKL).
- Smart Infrastructure Hub in Leipzig receives a further 1,9 million euros in funding
- Up to 130.000 euros in prize money: Saxony is again looking for the best start-up ideas, innovations and transfer projects
- 7,4 million euros capital reserve for a new innovation center at the old trade fair
- Leipzig Chamber of Industry and Commerce elects new general manager
- Application phase for the 19th IQ Innovation Prize started
- Online Event: The new Supply Chain Due Diligence Act - essential requirements for practice
- Conversion of the old trade fair center in Leipzig is progressing
- 66th Life Science Stammtisch in BIO CITY November 30.11th: Strengthening of SMEs through innovation – funding programs at state and federal level
- »German Business Angels Day«: Leipzig becomes the city of angels from November 26th to 28th
- Christmas market in the BIO CITY on November 29.11.22th, XNUMX
- Online Event: Leipzig Immune ONcology (LION) Conference on 22./23. November
- Experts present new drugs at "Bio Europe" in Leipzig
- Brussels approves 2,6 billion euros for investments in Saxony's regions and companies
- AfterWork free beer networking event on November 1st
- Leipzig University Hospital again among Germany's top 10
- BIO-Europe: European biotechnology industry meets in Saxony
- Six federal ministries are jointly anchoring One-Health in research: Successful research platform for zoonoses is being further developed
- Nobel Prize 2022 for Svante Pääbo
- BIO-Europe 2022 back in presence
- City of Leipzig joins biosaxony e. V. bei / branch association has been successfully committed to Leipzig for a long time
- Candidates wanted for the DECHEMA Prize
- AfterWork free beer network event on October 5th
- »No other region is better suited to this structural change«
- OFB starts construction work for technology campus "BioSquare Leipzig"
- »airea – The Airport Region in Central Germany« presents itself as an attractive location on FlyPharma
- Flu vaccination in the BIO CITY
- Leipzig University Hospital puts three new high-precision operating theaters into operation
- BioCityfit! - Bike check on 26.09.2022/XNUMX/XNUMX
- Digital Health Award Novartis
- AfterWork network event on September 7th
- c-LEcta reports a record year with significant growth
- BellaSeno starts clinical trials for resorbable breast implants
- dr Jörn-Sven Kühl, stem cell transplant expert at UKL: "ALD should be included in newborn screening"
- dr David Schaller receives the 2022 dissertation award from the Bioinformatics group
- AfterWork network event on August 10th
- MPI: The brains of Neanderthals developed differently than that of modern humans
- 7th place: Leipzig University Hospital again among the best hospitals in Germany
- FlyPharma Conference Europe Pre-Event at BIOCITY
- First robotic pancreas surgery at Leipzig University Hospital
- MEDICAL FORGE LEIPZIG lets the sparks fly
- Leipzig University Hospital: Investigating the causes of rare diseases in children
- AfterWork network event on July 06th!
- EY Biotechnology Report 2022: Biotech boom continues – but at a slightly lower level
- Fresh money and new offers: eCovery receives growth capital and completes its portfolio in the field of digital health
- Medical biotechnology helps people with rare diseases
- Fraunhofer IZI: Preclinical testing of an ATMP for the treatment of knee cartilage damage completed
- AfterWork networking event on 08th of June !
- Newly discovered enzyme breaks down PET plastic in record time
- Small but essential - recognition of peptides in receptor families
- CO.DON AG: The European Commission grants an indefinite extension of the EU-wide approval of the drug Spherox
- Annual meeting of the German Association of Independent Testing Laboratories (VUP) on June 23rd and 24.06.2022th XNUMX
- 64th Life Science Roundtable / networking event
- With the reorganization of the Management Board, Vita 34 is setting the course for accelerated growth in new business areas
- Call for participation: Online survey on the Saxon research landscape
- c-LEcta reaches agreement to be acquired by Kerry Group
- 22nd Saxon Founder's Prize: The application portal is open until March 9th
- Join Saxon booth at MEDICA 2022
- Medical technology fair Arab Health offers Saxon companies good opportunities to enter the growing market
- SMWK: The white paper is intended to provide new impetus for strengthening research in Saxony
- Study on the challenges and opportunities of vocational training in the LifeScience industry
- MPI EVA: Modern humans have evolved more effective protection against oxidative stress
- 2021
- European Social Fund: 673 million for promoting bright minds
- The Mexican Ambassador visiting CO.DON AG
- Innovation survey by the Chamber of Industry and Commerce (IHK) in Leipzig
- SaxoCOV survey: Saxony-wide survey of all citizens on the corona pandemic started
- c-LEcta - Market launch of a newly developed medical product: NuCLEANase®
- tediro receives a significant six-figure research grant from the Thuringian development bank for the further development of the mobile robotics platform
- COME ON BABY LIGHT MY FIRE - New medical technology forge in Saxony
- Hybrid conference: Energy Saxony Summit 2021 on December 09th in Dresden
- c-LEcta: OFB Projektentwicklung builds new headquarters for the biotechnology company
- futureSax: Saxon transfer forum "TransfERleben in Dresden" on November 3, 2021
- 30 years of Saxony Economic Development GmbH - on a constant road to success as a door opener, bridge builder and networker for the business location
- German-Polish-Czech science platform meets in Dresden from October 08th to 09.10.2021th, XNUMX
- Launch of the Living Lab and Graduate School for Artificial Intelligence
- Online Event: Leipzig Immune ONcology (LION) Conference, November 9-10, 2021
- Karliczek: 10 research groups on the late effects of Covid-19 are starting
- AKKA Technologies is expanding its digital offering and opening a new location for the "Digital Center of Excellence" (DCE) in Leipzig
- iDiv: New building of the research center in Leipzig inaugurated
- Study Health Market China: Drugs and Medical Biotechnology
- c-LEcta: Drug Master File for the use of the enzyme DENARASE® in the pharmaceutical industry accepted by the US FDA
- Online Event: Consensus building on product group specific PMCF endpoints for MDR purposes
- CO.DON AG: Start of production in Leipzig on time and within budget
- Prof. Toralf Kirsten takes over the newly created professorship and department for Medical Data Science
- Center for Medicine Innovation clears the first hurdle in the ideas competition for a new large-scale research center in central Germany
- Register now! German Biotechnology Days 2021 in Stuttgart
- Structural change as an opportunity: project started to qualify skilled workers in biotechnology
- Saxony sends relief supplies to Uganda
- Online Event: Long Night of Science Leipzig 2021
- Leipzig University: New Humboldt Professorship for AI
- Online Event: Presentation of the EY Biotech Report
- biosaxony: An industry takes stock - Saxon biotech solutions in the fight against the corona pandemic
- The AK BioRegio unanimously confirms Dr. Janin Sameith as the new speaker
- Associations call for industrial policy support for the medical technology sector
- CO.DON AG: GMP inspection by the higher federal authority and the Saxony State Directorate successfully completed at the Leipzig site
- c-LEcta: European dossiers submitted for the approval of new enzymes in the food industry
- Vita 34 AG signs merger agreement with Polski Bank Komórek Macierzystych SA
- CO.DON AG: Drug approved throughout the EU receives vote for extension of indication for use in adolescents
- Heavyweight of the University of Leipzig: 13 million euros for obesity research
- Innovation Award 2021 of the BioRegions in Germany
- Online event: Closing event of the innovation forum "Gamification for medical and health technology" from 15.-18. June 2021
- Spahn/Karliczek: Further impetus for the development and manufacture of supply-related drugs against COVID-19
- epitopic: Researchers want to develop a vaccine that protects against urinary tract infections
- Fraunhofer IZI: Inactivating pathogens with low-energy electrons
- Online Event: Saxon Innovation Exchange - Robotics and Automation
- Online Event: Saxon Investors Roadshow II 2021 as part of the futureSAX Innovation Conference
- CO.DON AG: Technology transfer completed by EMA
- Validation of research results: Saxony is experiencing strong demand - applicants receive the first funding notifications
- BioCity Fit! - Challenge in May
- Mannin and Cyclica enter Joint Venture to rapidly develop Covid-19 Drugs
- No increased suicide mortality during the first corona lockdown
- Public Value Award for Start-Ups 2021
- Online Event: Leipzig Immune ONcology Conference (LION) 2021
- BioCity Fit! - Offers in April
- c-LEcta: "We need a matching platform in the growth phase" - Interview with Thomas Pfaadt
- Online Event: Register now for the Saxon Foreign Trade Week 2021
- "More security, less search effort and a reduction in sources of error": Indical Bioscience relies on digital change and document management
- Start-up Quantum Technologies: Turck duotec relies on quantum sensors
- Leipzig University: "Molecular Whistleblowers"
- Karliczek: BioNTech founding couple Türeci/Şahin is a major win for health research in Germany
- T4M 2021 has been cancelled
- BVMed: SMEs suffer from a double burden
- BellaSeno: Production of implants - fully automated and cloud-based
- Merck and VivoSensMedical are evaluating new options for individualizing reproductive medicine
- MPI EVA: New corona test developed
- C-Lecta welcomes 100th employee
- BioCityfit! - Our current online offers for company health management
- DNB clicked in: A virtual look behind the scenes of the German National Library
- Cell biology: signal transmission without a signal
- Fiscal research funding: Information event organized by the Research Allowance Certification Office and the Federal Ministry of Finance
- Salaries in the future-oriented biotechnology sector are increasing
- Tumor physics: Cancer cells liquefy and squeeze through the tissue
- Fraunhofer IZI: Individualized cancer therapy will soon be faster and more effective thanks to artificial intelligence
- Online Event: Industry's Hidden Champions Conference 2021 - How world market leaders combine resilience and innovation
- MPI EVA: Neanderthal gene variants and Covid-19
- SaxoCell - "Living Medicines" Made in Saxony
- Diverse support for Saxony's start-up scene, transfer actors and innovators
- Offer of support for Saxon companies as part of participation in the CMEF 2021 trade fair - China International Medical Equipment Fair, Shanghai, May 13 - 16, 2021
- Online Event: "Systemically Human - The Future of Designing Interaction Work"
- Online Event: 3rd Saxon Digital Forum - Transparent processes as the basis for successful digitization
- Fraunhofer IZI: Optimization of novel immune cell therapies
- Vita 34: Stem cells from umbilical cord tissue - great potential in the treatment of corona diseases
- BVMed: Medtech 2030 initiative aims to strengthen Germany as a production and research location
- Online Event: Virtual InterSystems AI+ML Summit 2021
- Online Event: Digital Medicine Week 2021
- BREXIT: SPECTARIS sectors expect considerable additional bureaucracy
- 2020
- ERA PerMed: 4th call is open!
- BIO Germany yearbook 2020/2021 published
- CO.DON AG: Expansion of the board of directors to strengthen business activities
- c-LEcta continues its growth in 2020 and increases EBITDA above average
- iDiv: Gottfried Wilhelm Leibniz Prize 2021 of the German Research Foundation (DFG) goes to Saxony
- Five minute brainwave waveforms: A key to Parkinson's disease symptoms
- c-LEcta: Research project started for the industrial production of oligosaccharides by enzyme-based glycosylation
- ICCAS: Prof. Melzer and 3 ICCAS researchers at iSMIT
- SelfDiagnostics intends to apply for approval for a rapid at-home PCR-COVID19 test
- Quo vadis, MDR and DVG?
- Saxony lifts application freeze for research and development projects
- Action paper NanoBioMedizin 2020 published
- IQ Innovation Award Central Germany 2021 started with digital live event
- Large-scale research centers should lead Germany as a location for science and coalfields into the future
- Kick-off for the Digital Health Transformation (dht)
- Spectaris: Access to reimbursement system for medical devices remains too complex
- 23rd biosaxony on site: "Cutting Edge - Innovations in medicine through cell and gene therapy"
- Because of Corona: Liver transplant patient day on November 21st online only
- Crisis dampens industry growth
- FORSCH! Against the corona virus
- CO.DON AG: Results of the clinical phase III study
- Saxony supplements technology funding with an important building block for the validation of research results
- Prize of the Biotechnology Future Forum 2021
- Fraunhofer IZI: "Day of Immune Research 2020" by Fraunhofer CIMD
- 6th place in Germany: Leipzig University Hospital once again tops the list of TOP 100 hospitals published by "FOCUS Gesundheit"
- CO.DON AG: First Spherox transplantation successfully carried out in Switzerland
- Virtual Finance Day 2020 - "Corona as a turbo for biotechnology?"
- Marketingclub Leipzig is looking for prizewinners 2020
- Research with umbilical cord blood on the rise internationally
- Fraunhofer Solution Days
- MEDICA and COMPAMED take place virtually
- Neanderthal gene variant increases risk of severe course of Covid-19
- Saxon Transfer Forum - TransfERleben in Leipzig
- Saxon innovations meet capital
- General meeting of biosaxony eV 2020
- 54th Annual Meeting of the German Society for Biomedical Engineering - BMT 2020
- Ministry of Social Affairs gives the green light for Saxon pharmacies to issue corona antibody tests
- MIKA app gives cancer patients help to help themselves - modern cancer therapy assistant as a smartphone app
- Web conference: Digitization in diagnostics and clinics - opportunities and perspectives
- Online information event on funding opportunities in the field of health in Horizon Europe
- "Physics of Cancer" conference focuses on brain tumors
- Karliczek: Overcoming the corona pandemic with innovative medical products and diagnostics
- DIHK survey of manufacturers of in-vitro diagnostics until October 9, 2020
- Kretschmer sees "exciting and great future" for Saxony's biotechnology industry
- New cluster brochure for healthcare and biotechnology
- Blood, oxygen, food: modern organ perfusion equipment prepares donor livers
- Basis for further research on the actual spread of the corona virus in the population
- Renowned vaccine researcher comes to the University of Leipzig
- EU Commission: Strengthen medtech in Europe
- Biotechnology Days 2021 on September 20th and 21st in Stuttgart
- Innovative imaging methods in abdominal surgery at the University Hospital Leipzig
- More AI in German companies
- c-LEcta expands cooperation with pharmaceutical specialist logistics company "World Courier"
- RNA fusions for more targeted help in cancer
- Leipzig forges tomorrow's medical technology
- Application final sprint for the 2nd public ideas competition of the innovation region Central Germany
- Central German Unibund starts the "International Startup Campus"
- Research group astacin proteinases established at Fraunhofer IZI
- Biopharmaceuticals continue to grow
- Haptic Laboratory takes 1st place in the Ferry Porsche Challenge
- New type of antibiotic for periodontitis treatment developed at the Fraunhofer IZI wins overall victory at the IQ Innovation Prize Central Germany
- CO.DON AG: Gradual return to normal operations
- Neanderthal genes in a petri dish
- c-LEcta grows significantly in 2019, starts strongly in 2020
- Structural change in the central German mining area
- c-LEcta launches new product DENARASE ELISA Kit
- The medical technology industry is facing major challenges
- New research offensive
- Patented technology from the Fraunhofer IZI makes specific dengue virus diagnostics possible
- Stem cells from umbilical cord tissue: Studies investigate effectiveness in corona pneumonia
- Personalized 3D implants
- Q fever pathogen detected in tick faeces
- Applications for DiGAs from May
- Bioinformaticians delve deep into the developmental history of bacteria
- Leipzig pharmacologists are researching molecules against prostate cancer
- Researchers examine the role of work in the development of lifestyle diseases
- How computers could develop a corona vaccine
- European Parliament approves MDR postponement
- Millions in funding for better therapy for COPD patients
- Non-university research institutions in Saxony provide Covid19 test capacities
- WHZ co-develops 3D-printed emergency ventilator
- Vaccine research Artificial enzyme from Leipzig helps in the fight against Corona
- Research and medicine in Saxony join forces in the fight against Covid-1
- Karliczek: We support the national network of university medicine in the fight against Covid-19
- European Commission approves German guarantee measure to further support economy after coronavirus outbreak
- The EU Commission wants to suspend the MDR from the start of validity by one year
- biosaxony, DRESDEN-concept and many other partners support healthcare providers
- Speech disorders after a stroke: Networks in the brain help each other to compensate for damage
- Studies on the treatment of the most severe complications in people infected with the corona virus started in China
- The cause of Alzheimer's disease lies in brain evolution
- Information offensive on the corona virus in Saxony
- c-LEcta gains a new industrial partner and successfully continues development into a product company
- Better information - Leipzig e-health project "eMMa" in live trial operation
- Hitchhiker's Guide to Human Cells
- VITA 34 - What is pure must become even purer
- Successful start of the biosaxony working group "Cell Therapies"
- Bring virtual reality and voice assistants to the hospital
- Around 80 AI providers in Saxony, but need to catch up in knowledge transfer and application laboratories
- VITA 34 - Marketing experts visiting the award winner
- Relaunch of the market leader - Vita 34 revitalizes brand and portfolio
- 1,2 million euros for the Leipzig Medical Biobank
- Established Institute for Drug Development
- With the molecular "vacuum cleaner" against anemia in senile leukemia
- CO.DON receives manufacturing license for in-house and commissioned production at the Leipzig location
- University hospitals in Leipzig and Jena are developing a joint oncological center of excellence
- Zellkraftwerk/Canopy Biosciences: Immune Profiling Platform continues to grow
Online Event: Saxon Investors Roadshow II 2021 as part of the futureSAX Innovation Conference
The Free State of Saxony is well on the way to developing into one of the leading innovation regions in Europe. Many innovative ideas and business models are created here. futureSAX, the innovation platform of the Free State of Saxony, identifies and promotes high-potential investment cases and presents them as part of the Saxon Investors Roadshow.
At the 17th stage of the Saxon Investors Roadshow on July 13.07.2021, 15 from 20 p.m. to 15 p.m. online, you as an investor have the exclusive opportunity to get to know about XNUMX cutting-edge start-up and growth concepts "Made in Saxony". In addition to the usual pitch sessions, individual one-on-one meetings are possible and can be arranged in advance. You can find a review of the last investor roadshows in the Reports on the futureSAX homepage.
Participation as an investor
Participation in the event is limited and is aimed primarily at investors from the futureSAX investor network. Would you like to take part in the Saxon Investors Roadshow as an investor? Please use the online registration on the Events page.
The futureSAX investor network:
futureSAX offers investors suitable investment cases from founders and entrepreneurs with promising concepts in individual matching options. In order to benefit from these offers, we recommend creating a profile in our investor network.
FutureSAX project manager for investors, Alexander Kühne, can answer any further questions you may have alexander.kuehne@futuresax.de or on 0351 79 99 79 74.
Participation as a founder and entrepreneur: Apply now!
Apply for one of the coveted pitch positions by May 30, 2021 by submitting the following application documents investorenroadshow@futureSAX.de send!
Complete application:
- Completed futureSAX One-Pager (Template here download)
- Brief description (3-4 sentences) and company slogan (max. 10 words) in German for the programme
- Pitch deck (shipping version)
- Key points for the current status
- Implementation of the technology / product
- Business Model
- achieved milestones in the market
- Financing volume current round + already committed financing
previous news
Online Event: Saxon Innovation Exchange - Robotics and Automation
Good ideas deserve strong partners! Initiate cooperation between young & established companies online at the Saxon Innovation Exchange Robotics & Automation on May 26.05.2021, 10 from 12 a.m. to 30:XNUMX p.m.
NextNews
CO.DON AG: Technology transfer completed by EMA
The European Medicines Agency (EMA) granted CO.DON AG approval for its new manufacturing facility in Leipzig. The Leipzig site is now formally approved for the manufacture, quality control and market release of Spherox for the EU. This means that the EMA has all the official requirements to produce the drug in Leipzig and bring it to the EU market.
